India Exits Vaccine-Making Business By Transforming Four Units
This article was originally published in PharmAsia News
Executive Summary
India is no longer in the vaccine business, the country's health minister said. Until now, the government had operated four units to produce vaccines in case of emergencies, but health ministry officials say that backup no longer is necessary. Instead, the facilities are to be used for diagnostic testing, beginning in a few months, with unit employees retrained for their new jobs. The manufacturing licenses of the four units had been suspended in January because they no longer met good manufacturing practices standards. (Click here for more
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.